36th Annual New Treatments in Chronic Liver Disease CME Conference

Kongressthemen
This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail.

Kongressorganizer (PCO)
Scripps Health

Anmerkungen
Speakers: Paul J. Pockros, MD, FACG, Catherine T. Frenette, MD, FAST, AGAF, Michael B. Charlton, MD, FRCP, Adam Deising, DO, Julio A. Gutierrez, MD, Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, FAASLD and more.

https://go.evvnt.com/949222-0?pid=4832

Herr Scripps Conference Services and CME